
Vials
KPV 10mg
An alpha-MSH-derived tripeptide studied for anti-inflammatory action in gut, skin and immune research.
KPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). It retains α-MSH's anti-inflammatory activity while leaving out the parent hormone's pigmentation and other effects, making it a targeted tool for inflammation research. Each vial is supplied at 10mg of lyophilised peptide.
Specifications
Research Benefits
- Anti-inflammatory action — Research shows KPV inhibits inflammatory pathways including NF-κB and pro-inflammatory cytokines.
- Gut health research — Studied extensively in models of inflammatory bowel disease, colitis, and intestinal inflammation.
- Immune modulation — Demonstrates the ability to regulate immune responses without broad immunosuppression.
- Skin health interest — Investigated for wound healing and inflammatory skin conditions.
- Antimicrobial properties — Some research indicates activity against certain bacteria and fungi.
How It Works
Research has also shown KPV can enter cells — and even the nucleus — where it interacts directly with inflammatory signalling cascades, an intracellular action considered central to its potent anti-inflammatory profile in research models.
⚠ For Research Use Only
By purchasing, the buyer confirms this product is being acquired for legitimate research purposes and assumes full responsibility for its handling, storage, and use in compliance with all applicable local, national, and international laws.
More Vials

Vials
5-Amino-1MQ 50mg
A selective NNMT inhibitor studied for reducing fat-cell formation and preserving cellular NAD+ levels.
View
Vials
AOD-9604
A modified HGH fragment (176-191) studied for fat metabolism without growth-hormone-linked anabolic activity.
View
Vials
BPC-157 5mg
A gastric-derived pentadecapeptide extensively studied for tendon, gut and musculoskeletal tissue repair.
View